Navigation Links
WMIS Appoints Lisa Baird as Next Executive Director
Date:5/20/2013

Culver City, CA (PRWEB) May 20, 2013

The World Molecular Imaging Society (WMIS) Board of Trustees has announced the appointment of Lisa Baird as Executive Director. Baird will assume leadership of the WMIS on July 8, 2013. The WMIS vision is to encompass and promote preclinical and clinical multi-modal imaging applications to understand and effectively treat diseases in the developed and developing world. The World Molecular Imaging Society (WMIS) was established in 2011 by integrating the Academy of Molecular Imaging and the Society for Molecular Imaging into a single streamlined society focused on advancing the field of molecular imaging. WMIS also sponsors the World Molecular Imaging Congress.

“We are proud to welcome Ms. Baird as WMIS’ new Executive Director,” said Zaver Buhjawalla, PhD. Search Committee Chair and WMIS President. “With her background in preclinical and clinical molecular imaging, WMIS is poised for a bright future.”

Baird comes to WMIS with extensive experience as a senior executive with global experience leading corporate and product initiatives in Fortune 500 and start-up environments. Her background includes building and managing marketing organizations that focus on the Oncology care path from discovery to patient management. She has a record of achievement in managing biomarker, surgical, imaging, therapy and medical device brands.

“Lisa Baird has everything we were looking for in an Executive Director,” said Anna Wu, PhD and WMIS President-elect. “We were particularly impressed with her emphasis on reaching out to all sectors of the global molecular imaging community. This is an exciting time for WMIS.”

Baird has a successful record of achievement as a Marketing Executive in the Molecular Imaging (PET/CT, MRI, preclinical PET/SPECT/CT) and Radiation Therapy (Intraoperative RT) industry, most recently as Director of Strategic Market Development at Siemens Healthcare.

Baird notes that her “ responsibility has been to map the needs of basic scientists and clinicians, develop strategies, and implement programs that drive awareness, utilization and adoption of medical technology - a particularly good fit with WMIS. I am tremendously excited to be a part of WMIS and its emphasis on cutting edge science.”

Ms. Baird will be working with the current Executive Director, Kim Pierce, for the next few months to ensure a smooth transition as Pierce retires.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10748905.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Intra-Cellular Therapies Appoints Professor Sir Michael Rawlins to its Board of Directors
2. Alacrita Aggregates the Life Science Practices of Two Consulting Firms and Appoints Simon Turner Ph.D FRSC as Partner
3. Ohr Pharmaceutical Appoints Thomas M. Riedhammer To Board Of Directors
4. PDL BioPharma Appoints Peter Garcia as Chief Financial Officer
5. TNI BioTech, Inc. Appoints Industry Veteran, Dr. Joseph Fortunak, as a Strategic Consultant
6. VentiRx Pharmaceuticals Appoints James Kyle Bryan, M.D. as Chief Medical Officer
7. OHK Medical Devices appoints Mr. Omer Inbar as Chief Executive Officer
8. Vanda Pharmaceuticals Appoints Dr. Paolo Baroldi As Chief Medical Officer
9. First Warning Systems, Inc., Appoints Veteran Medical Executive Royea as CEO
10. California Healthcare Institute Appoints Associate Director, Federal Government Relations and Programs
11. Galien Foundation Appoints Kimberly Ha of Infinata’s BioPharm Insight to US Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... CA (PRWEB) , ... February 21, 2017 , ... ... its GMP cell therapy manufacturing facility at its headquarters laboratory in Poway, California. ... and utilizing the experience of both in-house personnel and consultants, VetStem constructed and ...
(Date:2/21/2017)... VANCOUVER, British Columbia , Feb. 21, 2017 /PRNewswire/ ... that apatorsen results from two randomized Phase 2 clinical trials ... 2017 Genitourinary Cancers Symposium, held February 16 th - 18 ... from trials in bladder and prostate cancers demonstrated apatorsen was ... standard-of-care treatments. ...
(Date:2/21/2017)... 21, 2017   Logicalis Healthcare Solutions , the ... and managed services provider ( www.us.logicalis.com ), today announced ... Epic. The new service will help hospital CIOs make ... giving physicians, nurses and other clinicians immediate access to ... This will allow hospital IT staff to focus on ...
(Date:2/21/2017)... , Feb. 21, 2017   Invitae Corporation ... information companies, today announced that members of the company,s ... 37th Annual Health Care Conference on Monday, March 6, ... Pacific in Boston, Massachusetts . ... may be accessed by visiting the investors section of ...
Breaking Biology Technology:
(Date:2/10/2017)... 2017 Research and Markets has ... Medicine - Scientific and Commercial Aspects" to their offering. ... ... integrated with therapy for selection of treatment as well for ... prevention of disease in modern medicine. Biochip/microarray technologies and next ...
(Date:2/8/2017)... Feb. 7, 2017 Report Highlights ... The global synthetic-biology market ... billion by 2021, growing at a compound annual growth rate ... overview of the global markets for synthetic biology. - Analyses ... 2016, and projections of compound annual growth rates (CAGRs) through ...
(Date:2/7/2017)... 7, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... will present at the LEERINK Partners 6th Annual Global ... on Wednesday, February 15, 2017 at 10 a.m. Eastern ... presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  The ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
Breaking Biology News(10 mins):